Worldwide the incidence and severity of COVID-19 within the pediatric population is markedly lower when compared to their counterpart in the general population. The disease creates a spectrum of presentations ranging from asymptomatic ones, to Multisystem Inflammatory Syndrome in Children (MIS-C). The majority of COVID-19 cases do not progress to MIC-S with the etiology of this progression largely unknown. Two major themes within the realm of MIC-S are the demanding course of the disease and its good prognosis [1-3].

Keywords: Multisystem Inflammatory Syndrome in Children (MIS-C); Pediatrics SARS-CoV-2 infection; MIS-C with AKI; MIS-C with kidney involvement